전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
haematological response
31% (25.2–36.8)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pilnīga hematoloģiska atbildes reakcija (complete haematological response – chr)
complete haematological response (chr)
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
pilnīga hematoloģiska atbildes reakcija (chr – complete haematological response) hf pacientiem tika vērtēta kā sekundārais mērķa kritērijs.
complete haematological response (chr) in cp patients was evaluated as a secondary endpoint.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
raĪ ir apņēmies kontrolēt vēnu okluzīvās slimības (vod) sastopamību pēc asinsrades celmšūnu pārstādīšanas (haematological stem cell transplant - hsct).
the mah has committed to monitor veno-occlusive disease (vod) after haematological stem cell transplant (hsct).
마지막 업데이트: 2012-04-10
사용 빈도: 2
품질:
pacientiem, kam reakcija uz terapiju izpalika (pilnīga hematoloģiska atbildes reakcija (complete haematological response - chr) izpaliek pēc 6 mēnešu ilgas terapijas, pieaug (white blood cells – wbc), 24 mēnešu laikā nav novērota nozīmīga citoģenētiska atbildes reakcija – mcyr), reakcija uz terapiju tika zaudēta (zūd chr vai mcyr) vai novēroja smagu izvēlētā terapijas veida nepanesamību, tika atļauts pāriet uz citu terapijas veidu.
patients showing lack of response (lack of complete haematological response (chr) at 6 months, increasing wbc, no major cytogenetic response (mcyr) at 24 months), loss of response (loss of chr or mcyr) or severe intolerance to treatment were allowed to cross over to the alternative treatment arm.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질: